Use of lutein and zeaxanthin alone or combined with brilliant blue to identify intraocular structures intraoperatively

Retina

Volumn 32, Issue 7, 2012, Pages 1328-1336

  Sousa Martins, Diogo ^a   Maia, Maurício ^a   Moraes, Milton ^a   Lima Filho, Acácio A S ^a   Rodrigues, Eduardo B ^a   Chen, Jane ^a   Farah, Michel E ^a   Santos, Leticia B ^a   Belfort, Rubens ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

blue; brilliant; capsule; chromovitrectomy; dye; internal limiting membrane; lutein; safety; vitreous; zeaxanthin

Indexed keywords

BRILLIANT BLUE; XANTHOPHYLL; ZEAXANTHIN;

ANTERIOR LENS CAPSULE; ARTICLE; CADAVER; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; ELECTRON MICROSCOPY; EYE; FORCEPS; HUMAN; INTERNAL LIMITING MEMBRANE; POSTERIOR CORTICAL HYALOID; POSTERIOR LENS CAPSULE; RETINA MACULA LUTEA; VITRECTOMY; VITREOUS BODY;

ANTERIOR CAPSULE OF THE LENS; BASEMENT MEMBRANE; BENZENESULFONATES; CATARACT EXTRACTION; COLORING AGENTS; DRUG COMBINATIONS; HUMANS; INTRAOPERATIVE PERIOD; LUTEIN; STAINING AND LABELING; VITREORETINAL SURGERY; VITREOUS BODY; XANTHOPHYLLS;

EID: 84862848805     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318239e2b6     Document Type: Article

References (47)

1. Rodrigues EB, Penha FM, et al. Historical aspects and evolution of the application of vital dyes in vitreoretinal surgery and chromovitrectomy. Dev Ophthalmol 2008;42:29-34.
2. Rodrigues EB, Meyer CH, Kroll P. Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthal-mol 2005;243:291-293. (Pubitemid 40823231)
3. Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000;107:2010-2014.
4. Rodrigues EB, Meyer CH, Farah ME, Kroll P. Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes. Ophthalmologica 2005;219:251-262. (Pubitemid 41208859)
5. Teba FA, Mohr A, Eckardt C, et al. Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003;110:2609-2612.
6. Kumar A, Prakash G. Differential staining with indocyanine green and trypan blue dye. Indian J Ophthalmol 2004;52:339. (Pubitemid 40116040)
7. Perrier M, Sebag M. Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol 2003;135:909-911. (Pubitemid 36677421)
8. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, et al. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-144. (Pubitemid 34240640)
9. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000; 20:554-555. (Pubitemid 32001537)
10. Mennel S, Meyer CH, Tietjen A, et al. Patent blue: a novel vital dye in vitreoretinal surgery. Ophthalmologica 2006;220: 190-193.
11. Schuettauf F, Haritoglou C, May CA, et al. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci 2006;47:3573-3578. (Pubitemid 351639726)
12. Jackson TL, Griffin L, Vote B, et al. An experimental method for testing novel retinal vital stains. Exp Eye Res 2005;81:446-454. (Pubitemid 41356508)
13. Haritoglou C, Yu A, Freyer W, et al. An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 2005;46:3315-3322. (Pubitemid 44264321)
14. Enaida H, Hisatomi T, Hata Y, et al. Brilliant Blue G selectively stains the internal limiting membrane/Brilliant Blue G-assisted membrane peeling. Retina 2006;26:631-636. (Pubitemid 44620362)
15. Enaida H, Hisatomi T, Goto Y, et al. Preclinical investigation of internal limiting membrane staining and peeling using intra-vitreal Brilliant Blue G. Retina 2006;26:623-630. (Pubitemid 44620361)
16. Farah ME, Maia M, Rodrigues EB. Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 2009;148:332-340.
17. Rodrigues EB, Penha FM, Costa EF, et al. Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol 2010;149:265-277.
18. Rodrigues EB, Costa EF, Penha FM, et al. The use of vital dyes in ocular surgery. Surv Ophthalmol 2009;54:576-617.
19. Costa EPF, Rodrigues EB, Farah ME, et al. Vital dyes and light sources for chromovitrectomy: comparative assessment of osmolarity, pH and spectrophotometry. Invest Ophthalmol Vis Sci 2008;49:6-7.
20. Rodrigues EB, Maia M, Meyer C, et al. Vital dyes for chro-movitrectomy. Curr Opin Ophthalmol 2007;18:179-187.
21. Mennel S, Thumann G, Peter S, et al. Influence of vital dyes on the function of the outer blood-retinal barrier in vitro. Klin Monatsbl Augenheilkd 2006;223:568-576.
22. Rodrigues EB, Maia M, Penha FM, et al. Técnica para injeção intravítrea de drogas no tratamento de doenças vitreorretini-anas. Arquivos Brasileiros Oftalmologia 2008;71:902-907.
23. Gandorfer A, Haritoglou C, Gandorfer A, Kampik A. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003;44:316-323. (Pubitemid 36134291)
24. Maia M, Margalit E, Lakhanpal R, et al. Effects of intravitreal indocyanine green injection in rabbits. Retina 2004;24:69-79. (Pubitemid 38240844)
25. Albini TH, Abd-El-Barr MM, Carvounis PE, et al. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci 2007;48:390-395. (Pubitemid 47251429)
26. Narayanan R, Mungcal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 2006;47:722-728. (Pubitemid 46768403)
27. Narayanan R, Kenney MC, Kamjoo S, et al. Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci 2005;46:304-309. (Pubitemid 40041212)
28. Rodrigues EB, Penha FM, Farah ME, et al. Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 2009;29:497-510.
29. Maia M, Farah ME, Rodrigues EB, Malerbi F. Subretinal Brilliant Blue G migration during internal limiting membrane peeling. Br J Ophthalmol 2009;93:330-331.
30. Penha FM, Maia M, Farah ME, et al. Morphologic and clinical effects of subretinal injection of indocyanine green and infra-cyanine green in rabbits. J Ocul Pharmacol Ther 2008;24: 52-61. (Pubitemid 351156632)
31. Maia M, Penha FM, Farah ME, et al. Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study. Graefes Arch Clin Exp Ophthalmol 2008;246:379-388.
32. Penha F, Maia M, Farah ME, et al. Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology 2007;114:899-908.
33. Maia M, Kellner L, De Juan E Jr, et al. Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 2004;24:80-91. (Pubitemid 38240845)
34. Maia M, Pieramici DJ, De Juan E Jr, et al. Retinal pigment and epithelium abnormalities after intravitreal injection of ICG to aid peeling of the internal limiting membrane in human eyes. Retina 2004;24:157-160. (Pubitemid 38240857)
35. Ahmed S, Lott M, Marcus D. The macular xanthophylls. Surv Ophthalmol 2005;50:183-193. (Pubitemid 40340949)
36. Seddon J, Ajani U, Sperduto R, et al. Dietary carotenoids, vitamins A, C and E, and advanced age-related macular degeneration. JAMA 1994;272:1413-1420. (Pubitemid 24328383)
37. Yemelyanov A, Katz N, Bernstein P. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 2001;72: 381-392. (Pubitemid 32977233)
38. Margrain T, Boulton M, Marshall J, Slinney D. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res 2004;23:523-531. (Pubitemid 39078360)
39. Bone R, Landrum J, Mayne S, et al. Macular pigment in donor eyes with and without AMD: a case control study. Invest Ophthalmol Vis Sci 2001;42:235-240. (Pubitemid 32059436)
40. Falsini B, Piccardi M, Iarossi G, et al. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy. Ophthalmology 2003;110:51-61.
41. Nolan J, Stack J, Mellerio J, et al. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res 2006;31:199-213.
42. Gonzalez S, Astner S, An W, et al. Dietary lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice. J Invest Dermatol 2003;121:399-405. (Pubitemid 36969915)
43. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Oph-thalmol 1993;111:104-109.
44. Snodderly D, Handelman G, Adler AJ. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 1991;32: 268-279.
45. Sommerburg O, Keunen J, Bird A, van Kuijk F. Fruits and vegetables that are sources for lutein and zeaxanthin: the mac-ular pigment in human eyes. Br J Ophthalmol 1998;82: 907-910. (Pubitemid 28408149)
46. Mares-Perlman J, Brady W, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113:1518-1523.
47. Gale C, Hall N, Phillips D, Martyn C. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 2001;108:1992-1998. (Pubitemid 33032766)